Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in gambian infants

Pediatric Infectious Disease Journal

Volumn 15, Issue 4, 1996, Pages 333-339

  Leach, Amanda ^a   Ceesay, Serign J ^a   Banya, Winston A S ^a   Greenwood, Brian M ^a,b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

conjugate vaccine; Gambian infants; Pneumococcus

Indexed keywords

DIPHTHERIA TOXIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MUTANT PROTEIN; PNEUMOCOCCUS VACCINE;

ANTIBODY TITER; ARTICLE; CHILDHOOD MORTALITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CRYING; DEVELOPING COUNTRY; DOSE RESPONSE; DRUG SAFETY; FEEDING DISORDER; FEVER; GAMBIA; HUMAN; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; LOBAR PNEUMONIA; PRIORITY JOURNAL; RASH; SIDE EFFECT; SOMNOLENCE; STREPTOCOCCUS PNEUMONIAE; TACHYPNEA; VOMITING;

ANTIBODIES, BACTERIAL; GAMBIA; HUMANS; IMMUNITY, ACTIVE; IMMUNIZATION; INFANT; INFANT, NEWBORN; PNEUMONIA, PNEUMOCOCCAL; VACCINES, SYNTHETIC;

EID: 0029944464     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199604000-00010     Document Type: Article

References (22)

1. Leowski J. Mortality from acute respiratory infections in children under 5 years of age; global estimates. World Health Stat Q 1986;39:138-44.
2. Denny FW, Loda PA. Acute respiratory infections are the leading cause of death in children in developing countries. Am J Trop Med Hyg 1986;35:1-2.
3. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis J 1986;5:247-52.
4. Wall RA, Corrah PT, Mahey DCW, Greenwood BM. The aetiology of lobar pneumonia in The Gambia. Bull WHO 1986;64:553-8.
5. Forgie IM, O'Neill KP, Lloyd-Evans N, et al. Etiology of acute lower respiratory tract infections in Gambian children: I. Acute lower respiratory tract infections in infants presenting at the hospital. Pediatr Infect Dis J 1991;10:33-41.
6. Forgie IM, O'Neill KP, Lloyd-Evans N, et al. Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J 1991;10:42-7.
7. Adegbola RA, Falade AG, Sam BE, et al. The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J 1994;13:975-82.
8. De Francisco A, Hall AJ, Armstrong Schellenberg JRM, Greenwood AM, Greenwood BM. The pattern of infant and childhood mortality in Upper River Division, The Gambia. Ann Trop Paediatr 1993;13:345-52.
9. O'Dempsey TJD, McArdle TF, Lloyd-Evans N, et al. Pneumococcal disease in children in Upper River Division, The Gambia. Pediatr Infect Dis J (in press).
10. Banya WAS, O'Dempsey TJD, McArdle T, Lloyd-Evans N, Greenwood BM. Predictors for a positive blood culture in African children with pneumonia. Pediatr Infect Dis J 1996;15:292-7.
11. Sazawal S, Black RE. Meta-analysis of intervention trials on case-management of pneumonia in community settings. Lancet 1992;340:528-33.
12. Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis 1983;148:131-7.
13. Koskela M, Leinonen M, Häivä VM, Timonen M, Makela PM. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis J 1986;5:45-50.
14. Pomat WAS, Lehman D, Sanders RC, et al. Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea. Infect Immun 1994;62:1848-53.
15. Temple K, Greenwood BM, Inskip H, Hall A, Koskela M, Leinonen M. Antibody response to pneumococcal capsular polysaccharide vaccine in African children. Pediatr Infect Dis J 1991;10:386-90.
16. Peeters CCAM, Tenbergen-Meekes AM, Haagmans B, et al. Pneumococcal conjugate vaccines. Immunol Lett 1991;30:267-74.
17. Paton JC, Lock RA, Lee CJ, et al. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun 1991;59:2297-304.
18. Schneerson R, Levi L, Robbins JB, Bryla DM, Schiffman G, Lagergard T. Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin. Infect Immun 1992;60:3528-32.
19. Vella PP, Marburg S, Staub JM, et al. Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F and 23F and a meningococcal outer membrane protein complex. Infect Immun 1992;60:4977-83.
20. Fattom A, Lue C, Szu SC, et al. Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid. Infect Immun 1990;58:2309-12.
21. Steinhoff MC, Edwards K, Keyserling H, et al. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: effect of polysaccharide size and linkage characteristics. Pediatr Infect Dis J 1994;13:368-72.
22. Twumasi PA, Kumah S, Leach A, et al. A trial of a group A + C meningococcal polysaccharide/protein conjugate vaccine in African infants. J Infect Dis 1994;171:632-8.